In a dramatic turn of events, Paramount Skydance is making a hostile bid for Warner Bros. Discovery after losing out to Netflix. With a $30-per-share all-cash offer, Paramount aims to sway WBD shareholders and navigate regulatory challenges in a fiercely competitive media landscape.
Discover the top 10 stock updates and analyst recommendations for November 11, featuring CoreWeave's revenue miss, Linde's upgrade, and Rocket Lab's soaring shares. Get insights into market trends and investment strategies!
The FDA has removed black box warnings on estrogen treatments for menopause, igniting a debate about the benefits and risks of hormone therapy. Dr. Marty Makary discusses the implications for women's health.
Jaafar Jackson showcases his incredible dance skills in the teaser for the Michael Jackson biopic directed by Antoine Fuqua. Set to release on April 24, 2026, this film promises an intimate look at the King of Pop's life beyond his iconic music.
Get ready for a star-studded celebration as Dancing with the Stars marks its 20th anniversary! Expect surprises, returning champions, and new twists in the upcoming episode. Don't miss out on the action!
E.l.f. Beauty's acquisition of Hailey Bieber's Rhode is projected to add $200 million to annual sales, but disappointing guidance led to a 29% stock drop. Can Rhode save E.l.f. from its fiscal woes?
This week's Dancing with the Stars paid tribute to the Rock & Roll Hall of Fame with classic rock hits and a special guest judge. Highlights include dances honoring the Dodgers' World Series win and a surprising elimination!
Norway's $2 trillion sovereign wealth fund has voted against Elon Musk's massive pay package at Tesla, defying management guidance amid a heated shareholder meeting. With Musk threatening to step down, tensions are rising as investors express concerns over executive compensation.
Jon Stewart extends his hosting role on The Daily Show for another year, continuing to bring his unique perspective to late-night comedy. Despite challenges, he remains committed to the show.
The American Academy of Pediatrics advises against the routine use of leucovorin for children with autism, citing insufficient evidence and urging caution amid rising parental demand for the treatment.